Abstract
Antibodies or immunoglobulin are glycoproteins produced by B-cells and play a central role in host immune defense. The immune response to any given antigen is diverse, comprising different antibodies exhibiting different affinities and/or epitope specificities. The conventional antibodies consist of a heavy (H) chain and a light (L) chain, each containing variable and constant regions. In Camelidae (camels and llamas) apart from the conventional antibodies, additional class of functional antibodies consisting of only heavy chains (HCAbs) is also present . The antigen (Ag)-binding site of these antibodies is composed solely of variable domain (VHH) with a mass of 15000 Da.
Keywords
- Bispecific Antibody
- Enzyme Fusion
- Genetic Engineering Technique
- Oral Immunotherapy
- Conventional Antibody
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
De Genst E, Saerens D, Muyldermans S, Conrath KE. Antibody repertoire development in camelids. Dev Comp Immunol. 2006;30:187–98.
Harmsen MM, de Haard H. Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol. 2007;77:13–22.
Muyldermans S. Single domain camel antibodies: current status. J Biotechnol. 2001;74:277–302.
Ghahroudi MA, Desmyter A, Wyns L, Hamers R, Muyldermans S. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett. 1997;414:521–6.
Coppieters K, Dreier T, Silence K, de Haard H, Lauwereys M, Casteels P, Beirnaert E, Jonckheere H, Van de Wiele C, StaelensL Hostens J, Revets H, RemautE Elewaut D, Rottiers P. Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis. Arthritis Rheum. 2006;54:1856–66.
Baral TN, Magez S, Stijlemans B, Conrath K, Vanhollebeke B, Pays E, Muyldermans S, De Baetselier P. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor. Nat Med. 2006;12:580–4.
Muyldermans S, Baral TN, Cortez-Retamozzo V, De Baetselier P, De Genst E, Kinne J, Leonhardt H, Magez S, Nguyen VK, Revets H, Rothbauer U, StijlemansB, Tillib S, Wernery U, Wyns L, Hassanzadeh-GhassabehGh, Saerens D. Camelid immunoglobulins and nanobody technology. Vet Immunol Immunopathol. 2008:1–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Ray Banerjee, E. (2016). Figures of Quantifiable Data in Support of Achieved Goals. In: Perspectives in Translational Research in Life Sciences and Biomedicine. Springer, Singapore. https://doi.org/10.1007/978-981-10-0989-1_12
Download citation
DOI: https://doi.org/10.1007/978-981-10-0989-1_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-0988-4
Online ISBN: 978-981-10-0989-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)